MAYAIR(SH:688376)2024-05-23 07:36Financial Performance - In 2023, the company achieved a revenue of CNY 150,530.91 million, representing a year-on-year growth of 22.68% [3] - The net profit attributable to shareholders was CNY 17,323.27 million, with a year-on-year increase of 40.76% [3] - For Q1 2024, revenue reached CNY 27,324.91 million, a growth of 2.08% year-on-year, while net profit was CNY 3,539.20 million, up by 5.44% [3] Business Segments - Cleanroom air purification business generated revenue of CNY 112,300.80 million, growing by 28.61% compared to the previous year [4] - Revenue from other business segments was CNY 38,230.11 million, reflecting an 8.05% increase [4] - The company’s product categories saw revenue of CNY 129,822.78 million from fan filter units and filters, a growth of 32.35%, while other products generated CNY 20,708.13 million, down by 15.86% [4] Supply Chain and Materials - Over 50% of raw materials are sourced domestically, with a focus on replacing imports to improve gross margins [3] - The company is actively developing upstream suppliers to enhance local sourcing [3] Research and Development - R&D expenses in 2023 amounted to CNY 7,011.23 million, accounting for 4.66% of total revenue [4] - The company holds a total of 159 patents, including 26 invention patents and 75 utility model patents [4] Market Position and Competition - The company holds a market share of approximately 30% in the domestic semiconductor cleanroom sector [5] - Competitors include international brands like CAMFIL and AAF, but domestic brands are increasingly gaining market dominance [5] Revenue Recognition and Order Fulfillment - The typical order fulfillment period is 2-3 months, influenced by client project timelines [5] - Revenue recognition occurs either upon delivery or upon project completion, with larger projects averaging a 6-9 month acceptance period [5] Future Outlook - The company aims to expand its presence in the overseas semiconductor market while stabilizing domestic revenue [8] - Plans include enhancing market share in the biopharmaceutical sector and developing air purification solutions in response to global clean energy initiatives [8]